Mental Health Screening Tools & Psychiatric Calculators
Evidence-based mental health screening tools and psychiatric assessment calculators for depression, anxiety, bipolar disorder, and substance use disorders. These validated instruments support clinical decision-making in primary care and psychiatric settings.
Why This Matters
Mental health disorders affect one in eight people worldwide, with depression as the leading cause of disability. The WHO reports that anxiety disorders affect 301 million people globally, while alcohol use disorders affect 283 million. Despite this high prevalence, a significant treatment gap exists — over 70% of people with mental health conditions in low- and middle-income countries receive no treatment. Validated screening tools like PHQ-9, GAD-7, and AUDIT-C bridge this gap by enabling early detection in primary care settings. The US Preventive Services Task Force (USPSTF) recommends depression screening for all adults, and the WHO's Mental Health Gap Action Programme (mhGAP) endorses these tools for use in non-specialized settings.
When to Use
Use PHQ-9 for depression screening and severity monitoring in adults. Use GAD-7 for generalized anxiety disorder screening. Use AUDIT-C for alcohol use disorder screening in primary care. Use CAGE for rapid alcohol dependence screening. Use MDQ for bipolar disorder screening when mood instability is suspected. These tools are designed for screening, not diagnosis — positive screens require comprehensive clinical evaluation.
Available Mental Health Calculators
PHQ-9
The Patient Health Questionnaire-9 (PHQ-9) is a validated 9-item screening tool used to assess the severity of depression and monitor treatment response. It is widely used in primary care and psychiatric settings worldwide.
Calculate →GAD-7
The Generalized Anxiety Disorder-7 (GAD-7) is a validated 7-item screening tool used to assess the severity of generalized anxiety disorder and monitor treatment response. It is widely used in primary care, psychiatric, and research settings.
Calculate →AUDIT-C
The Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) is a validated 3-item screening tool for identifying hazardous drinking patterns and alcohol use disorders. It is widely used in primary care, emergency departments, and research settings.
Calculate →CAGE
The CAGE questionnaire is a brief 4-question screening tool for alcohol dependence. It is one of the most widely used alcohol screening instruments globally, valued for its simplicity and speed.
Calculate →MDQ
The Mood Disorder Questionnaire (MDQ) is a validated 13-item screening tool for bipolar spectrum disorders, including bipolar I, bipolar II, and bipolar NOS. It helps identify individuals who may have experienced manic or hypomanic episodes.
Calculate →PCL-5
The PCL-5 is a 20-item self-report measure assessing the presence and severity of PTSD symptoms based on DSM-5 criteria. It covers intrusion, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity.
Calculate →YMRS
The Young Mania Rating Scale (YMRS) is an 11-item clinician-rated scale used to assess the severity of manic symptoms in patients with bipolar disorder. It is one of the most widely used instruments for evaluating mania in clinical and research settings.
Calculate →SAD PERSONS
The SAD PERSONS scale is a 10-item clinical assessment tool for evaluating suicide risk. It uses a simple mnemonic-based scoring system to stratify patients into low, moderate, and high risk categories to guide clinical decision-making.
Calculate →BPRS
The Brief Psychiatric Rating Scale (BPRS) is an 18-item clinician-rated scale that measures psychiatric symptoms such as depression, anxiety, hallucinations, and unusual thought content. It is widely used in clinical psychiatry and research.
Calculate →CAGE-AID
The CAGE-AID (Cut down, Annoyed, Guilty, Eye-opener — Adapted to Include Drugs) is a 4-question screening tool adapted from the original CAGE alcohol questionnaire to screen for drug use disorders. It is a brief and effective tool for identifying potential substance abuse problems.
Calculate →
Clinical Guidelines
- USPSTF Recommendation: Screening for Depression in Adults (2023)
- NICE Guideline NG222: Depression in Adults (2022)
- NICE Guideline NG113: Generalised Anxiety Disorder (2023)
- WHO mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders (Version 2.0)
- APA Clinical Practice Guideline for the Treatment of Depression (2023)
Frequently Asked Questions
Integrate these tools into your clinic workflow with Tabeeb+
Try Tabeeb+ for Your Clinic